Literature DB >> 7482395

Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.

B Dahlbäck1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7482395

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  12 in total

1.  Incidence of factor V Leiden in patients with acute myocardial infarction.

Authors:  M S Gowda; M L Zucker; J L Vacek; W L Carriger; D L Van Laeys; J M Rachel; B D Strope
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

2.  Mini-gastric bypass in a patient homozygous for Factor V Leiden.

Authors:  Cesare Peraglie
Journal:  Obes Surg       Date:  2007-01       Impact factor: 4.129

3.  After a first episode of venous thromboembolism.

Authors:  C N Chesterman
Journal:  BMJ       Date:  1995-09-16

4.  Activated protein C and retinal vein occlusion.

Authors:  B J Hunt
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

Review 5.  Regulation of the protein C anticoagulant and antiinflammatory pathways.

Authors:  A R Rezaie
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

6.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

Review 7.  Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Authors:  J P Vandenbroucke; F J van der Meer; F M Helmerhorst; F R Rosendaal
Journal:  BMJ       Date:  1996-11-02

Review 8.  Stroke in young adults and children.

Authors:  B H Bendixen; J Posner; R Lango
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

Review 9.  The effect of factor V Leiden carriage on maternal and fetal health.

Authors:  Dena Bloomenthal; Peter von Dadelszen; Robert Liston; Laura Magee; Peter Tsang
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

10.  Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.

Authors:  E Mandala; C Lafaras; C Tsioni; M Speletas; A Papageorgiou; D Kleta; T Dardavessis; G Ilonidis
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.